A study for a 28 year old woman who takes Minastrin 24 Fe - from FDA reports


Summary

1,317 females aged 28 (±5) who take the same drug are studied. This is a personalized study for a 28 year old female patient who has Alopecia. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Sep, 02, 2017

1,317 females aged 28 (±5) who take Minastrin 24 Fe are studied.


Number of reports submitted per year:

Minastrin 24 Fe for a 28-year old woman.

Information of the patient in this study:

  • Age: 28
  • Gender: female
  • Conditions: Alopecia
  • Drugs taken:
    • Minastrin 24 Fe (ethinyl estradiol; norethindrone acetate)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Hairloss: 1 (0.08% of females aged 28 (±5) who take the drug)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common side effects over time

< 1 month:
  • nausea
  • headache
  • vaginal bleeding between periods
  • depression
  • muscle spasms
  • pulmonary embolism
  • abdominal pain upper
  • weight increased
  • breast pain
  • weakness
1 - 6 months:
  • pulmonary embolism
  • breathing difficulty
  • thrombosis
  • nausea
  • fatigue
  • deep venous thrombosis
  • vaginal bleeding between periods
  • heavy or prolong menstrual bleeding
  • stroke
  • muscle spasms
6 - 12 months:
  • stress and anxiety
  • depression
  • insomnia
  • suicidal ideation
  • amenorrhea
  • mental disorder
  • pancreatitis
  • thrombosis
  • taste - impaired
  • wound
1 - 2 years:
  • dizziness
  • chest pain
  • pulmonary embolism
  • headache
  • hemiparesis
  • heavy or prolong menstrual bleeding
  • thrombosis
  • pain in extremity
  • gallstones
  • speech impairment (adult)
2 - 5 years:
  • gallstones
  • pain
  • jaundice - yellow skin
  • pulmonary embolism
  • amenorrhea
  • fatigue
  • depression
  • abdominal pain
  • irritable bowel syndrome
  • deep venous thrombosis
5 - 10 years:
  • irritability
  • suicidal ideation
  • insomnia
  • homicidal ideation
  • breast pain
  • loss of consciousness
  • aggression
  • vaginal bleeding between periods
  • abnormal dreams
  • deep venous thrombosis
10+ years:
  • anovulatory cycle
  • pulmonary embolism
  • deep venous thrombosis
  • menstrual disorder
  • amenorrhea
  • vena cava thrombosis
  • abdominal pain lower
  • solar urticaria
  • iucd complication
  • pulmonary thrombosis
not specified:
  • nausea
  • stress and anxiety
  • pain
  • abdominal pain
  • headache
  • depression
  • gallstones
  • pulmonary embolism
  • nausea and vomiting
  • cholecystitis chronic

Top conditions involved for these people *:

  • Oral Contraception (67 people, 5.09%)
  • Depression (62 people, 4.71%)
  • Acne (61 people, 4.63%)
  • Narcolepsy (58 people, 4.40%)
  • Crohn's Disease (55 people, 4.18%)

Top co-used drugs for these people *:

  • Yasmin (113 people, 8.58%)
  • Yaz (104 people, 7.90%)
  • Humira (94 people, 7.14%)
  • Accutane (62 people, 4.71%)
  • Xyrem (57 people, 4.33%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Alopecia, Minastrin 24 fe, Hairloss

You may be interested in these reviews

More reviews for: Alopecia, Minastrin 24 fe, Hairloss